Amphastar Pharmaceuticals (AMPH) Amortization of Deferred Charges (2021 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Amortization of Deferred Charges of $2.1 million for Q1 2026, up 34.17% year-over-year from $1.6 million in Q1 2025, and up 30.26% quarter-over-quarter from $1.6 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Amortization of Deferred Charges history runs 6 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- In Q1 2026, Amortization of Deferred Charges rose 34.17% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $4.8 million (up 213.48% YoY), while the FY2025 annual figure was $6.5 million, up 53.52% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $2.1 million, up from $1.6 million in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $6.7 million in Q3 2023, with the low at -$1.1 million in Q4 2024.
- The 5-year median for Amortization of Deferred Charges is $828000.0 (2022), against an average of $1.3 million.
- Peak annual rise in Amortization of Deferred Charges reached 1561.02% in 2024, while the deepest fall reached 136.73% in 2024.
- Amphastar Pharmaceuticals' Amortization of Deferred Charges stood at $902000.0 in 2022, then soared by 222.95% to $2.9 million in 2023, then sank by 136.73% to -$1.1 million in 2024, then jumped by 253.83% to $1.6 million in 2025, then jumped by 30.26% to $2.1 million in 2026.
- Business Quant data shows AMPH's Amortization of Deferred Charges at $2.1 million in Q1 2026, $1.6 million in Q4 2025, and $500000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Amphastar Pharmaceuticals | 938.56 Mn | 648.44 Mn | 93.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 500,000.00 |
| Jun 30, 2026 | 500,000.00 |
| Mar 31, 2026 | 2.14 Mn |
| Mar 31, 2026 | 2.14 Mn |
| Dec 31, 2025 | 1.65 Mn |
| Dec 31, 2025 | 1.65 Mn |
| Sep 30, 2025 | 500,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Jun 30, 2025 | 500,000.00 |
| Jun 30, 2025 | 500,000.00 |
| Mar 31, 2025 | 1.60 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Dec 31, 2024 | -1.07 Mn |
| Dec 31, 2024 | -1.07 Mn |
| Sep 30, 2024 | 500,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | 980,000.00 |
| Mar 31, 2024 | 980,000.00 |